Mackenzie Financial
TPTX

Mackenzie Financial’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Mackenzie Financial’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,209
Closed -$241K – 1540
2022
Q2 		$241K Buy
+3,209
New +$143K ﹤0.01% 1201

Mackenzie Financial's TPTX Position: Q3 2022 in Review

Mackenzie Financial sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 3,209 shares — an estimated $241K sold.

Mackenzie Financial first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $241K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Mackenzie Financial reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Mackenzie Financial sold 3,209 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $241K.
  • Mackenzie Financial first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Mackenzie Financial's Turning Point Therapeutics, Inc. Common Stock position peaked at $241K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Mackenzie Financial's 13F filing for Q3 2022, filed 7 Oct 2022.